101
Participants
Start Date
March 31, 2005
Primary Completion Date
February 28, 2011
Study Completion Date
May 31, 2011
DDD60 (INSIGNIA® pacing systems Guidant (Boston Scientific)
pacing in DDD60 is supposed to prevent events of syncope, presyncope of cardioinhibitory origin and symptom associated to av block
DDD60 (INSIGNIA® pacing systems Guidant (Boston Scientific)
pacing in DDDI30 is supposed to act as a safety backup upfront to episodes of syncope, presyncope or AV block, but not supposed to reduce symptoms.
Ospedale Santa Maria Annunziata, Bagno a Ripoli
Azienda Ospedaliera S. Sebastiano, Caserta
Ospedale Valduce, Como
Azienda Ospedaliera Osp. Maggiore, Crema
Nuovo Ospedale S. Giovanni di Dio, Florence
Ospedale Villa Scassi, Genova
Ospedale Umberto I, Mestre
Ospedale GB Grassi, Ostia - Roma
Ospedale Civile G. De Lellis, Rieti
Azienda Ospedaliera S. Filippo Neri, Roma
Ospedale Sandro Pertini, Roma
Policlinico Casilino, Roma
Lead Sponsor
Boston Scientific Corporation
INDUSTRY